Cargando…

Mesenteric lymph nodes as alternative site for pancreatic islet transplantation in a diabetic rat model

BACKGROUND: Islet transplantation has progressively become a safe alternative to pancreas transplantation for the treatment of type 1 diabetes. However, the long-term results of islet transplantation could be significantly increased by improving the quality of the islet isolation technique even expl...

Descripción completa

Detalles Bibliográficos
Autores principales: Veroux, Massimiliano, Bottino, Rita, Santini, Roberta, Bertera, Suzanne, Corona, Daniela, Zerbo, Domenico, Li Volti, Giovanni, Ekser, Burcin, Puzzo, Lidia, Raffaele, Marco, Lo Bianco, Salvatore, Giaquinta, Alessia, Veroux, Pierfrancesco, Vanella, Luca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402566/
https://www.ncbi.nlm.nih.gov/pubmed/31074398
http://dx.doi.org/10.1186/s12893-018-0452-x
_version_ 1783566784911114240
author Veroux, Massimiliano
Bottino, Rita
Santini, Roberta
Bertera, Suzanne
Corona, Daniela
Zerbo, Domenico
Li Volti, Giovanni
Ekser, Burcin
Puzzo, Lidia
Raffaele, Marco
Lo Bianco, Salvatore
Giaquinta, Alessia
Veroux, Pierfrancesco
Vanella, Luca
author_facet Veroux, Massimiliano
Bottino, Rita
Santini, Roberta
Bertera, Suzanne
Corona, Daniela
Zerbo, Domenico
Li Volti, Giovanni
Ekser, Burcin
Puzzo, Lidia
Raffaele, Marco
Lo Bianco, Salvatore
Giaquinta, Alessia
Veroux, Pierfrancesco
Vanella, Luca
author_sort Veroux, Massimiliano
collection PubMed
description BACKGROUND: Islet transplantation has progressively become a safe alternative to pancreas transplantation for the treatment of type 1 diabetes. However, the long-term results of islet transplantation could be significantly increased by improving the quality of the islet isolation technique even exploring alternative islet transplantation sites to reduce the number of islets required to mitigate hyperglycemia. The goal of the study was to test the lymph node as a suitable anatomical location for islet engraftment in a rodent model. METHODS: Forty Lewis rats, 6–8 weeks old, body weight 250–300 g, have been used as islet donors and recipients in syngeneic islet transplantation experiments. Ten rats were rendered diabetic by one injection of 65 mg/Kg of streptozotocin. After pancreas retrieval from non diabetic donors, islet were isolated and transplanted in the mesenteric lymph nodes of 7 diabetic rats. Rats were followed for 30 days after islet transplantation. RESULTS: A total of 7 islet transplantations in mesenteric lymph nodes have been performed. Two rats died 24 and 36 h after transplantation due to complications. No transplanted rat acquired normal glucose blood levels and insulin independence after the transplantation. However, the mean blood levels of glycemia were significantly lower in transplanted rats compared with diabetic rats (470.4 mg/dl vs 605 mg/dl, p 0.04). Interestingly, transplanted rats have a significant weight increase after transplantation compared to diabetic rats (mean value 295 g in transplanted rats vs 245 g in diabetic rats, p < 0.05), with an overall improvement of social activities and health. Immunohistochemical analysis of the 5 mesenteric lymph nodes of transplanted rats demonstrated the presence of living islets in one lymph node. CONCLUSIONS: Although islet engraftment in lymph nodes is possible, islet transplantation in lymph nodes in rats resulted in few improvements of glucose parameters.
format Online
Article
Text
id pubmed-7402566
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-74025662020-08-07 Mesenteric lymph nodes as alternative site for pancreatic islet transplantation in a diabetic rat model Veroux, Massimiliano Bottino, Rita Santini, Roberta Bertera, Suzanne Corona, Daniela Zerbo, Domenico Li Volti, Giovanni Ekser, Burcin Puzzo, Lidia Raffaele, Marco Lo Bianco, Salvatore Giaquinta, Alessia Veroux, Pierfrancesco Vanella, Luca BMC Surg Research Article BACKGROUND: Islet transplantation has progressively become a safe alternative to pancreas transplantation for the treatment of type 1 diabetes. However, the long-term results of islet transplantation could be significantly increased by improving the quality of the islet isolation technique even exploring alternative islet transplantation sites to reduce the number of islets required to mitigate hyperglycemia. The goal of the study was to test the lymph node as a suitable anatomical location for islet engraftment in a rodent model. METHODS: Forty Lewis rats, 6–8 weeks old, body weight 250–300 g, have been used as islet donors and recipients in syngeneic islet transplantation experiments. Ten rats were rendered diabetic by one injection of 65 mg/Kg of streptozotocin. After pancreas retrieval from non diabetic donors, islet were isolated and transplanted in the mesenteric lymph nodes of 7 diabetic rats. Rats were followed for 30 days after islet transplantation. RESULTS: A total of 7 islet transplantations in mesenteric lymph nodes have been performed. Two rats died 24 and 36 h after transplantation due to complications. No transplanted rat acquired normal glucose blood levels and insulin independence after the transplantation. However, the mean blood levels of glycemia were significantly lower in transplanted rats compared with diabetic rats (470.4 mg/dl vs 605 mg/dl, p 0.04). Interestingly, transplanted rats have a significant weight increase after transplantation compared to diabetic rats (mean value 295 g in transplanted rats vs 245 g in diabetic rats, p < 0.05), with an overall improvement of social activities and health. Immunohistochemical analysis of the 5 mesenteric lymph nodes of transplanted rats demonstrated the presence of living islets in one lymph node. CONCLUSIONS: Although islet engraftment in lymph nodes is possible, islet transplantation in lymph nodes in rats resulted in few improvements of glucose parameters. BioMed Central 2019-04-24 /pmc/articles/PMC7402566/ /pubmed/31074398 http://dx.doi.org/10.1186/s12893-018-0452-x Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Veroux, Massimiliano
Bottino, Rita
Santini, Roberta
Bertera, Suzanne
Corona, Daniela
Zerbo, Domenico
Li Volti, Giovanni
Ekser, Burcin
Puzzo, Lidia
Raffaele, Marco
Lo Bianco, Salvatore
Giaquinta, Alessia
Veroux, Pierfrancesco
Vanella, Luca
Mesenteric lymph nodes as alternative site for pancreatic islet transplantation in a diabetic rat model
title Mesenteric lymph nodes as alternative site for pancreatic islet transplantation in a diabetic rat model
title_full Mesenteric lymph nodes as alternative site for pancreatic islet transplantation in a diabetic rat model
title_fullStr Mesenteric lymph nodes as alternative site for pancreatic islet transplantation in a diabetic rat model
title_full_unstemmed Mesenteric lymph nodes as alternative site for pancreatic islet transplantation in a diabetic rat model
title_short Mesenteric lymph nodes as alternative site for pancreatic islet transplantation in a diabetic rat model
title_sort mesenteric lymph nodes as alternative site for pancreatic islet transplantation in a diabetic rat model
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402566/
https://www.ncbi.nlm.nih.gov/pubmed/31074398
http://dx.doi.org/10.1186/s12893-018-0452-x
work_keys_str_mv AT verouxmassimiliano mesentericlymphnodesasalternativesiteforpancreaticislettransplantationinadiabeticratmodel
AT bottinorita mesentericlymphnodesasalternativesiteforpancreaticislettransplantationinadiabeticratmodel
AT santiniroberta mesentericlymphnodesasalternativesiteforpancreaticislettransplantationinadiabeticratmodel
AT berterasuzanne mesentericlymphnodesasalternativesiteforpancreaticislettransplantationinadiabeticratmodel
AT coronadaniela mesentericlymphnodesasalternativesiteforpancreaticislettransplantationinadiabeticratmodel
AT zerbodomenico mesentericlymphnodesasalternativesiteforpancreaticislettransplantationinadiabeticratmodel
AT livoltigiovanni mesentericlymphnodesasalternativesiteforpancreaticislettransplantationinadiabeticratmodel
AT ekserburcin mesentericlymphnodesasalternativesiteforpancreaticislettransplantationinadiabeticratmodel
AT puzzolidia mesentericlymphnodesasalternativesiteforpancreaticislettransplantationinadiabeticratmodel
AT raffaelemarco mesentericlymphnodesasalternativesiteforpancreaticislettransplantationinadiabeticratmodel
AT lobiancosalvatore mesentericlymphnodesasalternativesiteforpancreaticislettransplantationinadiabeticratmodel
AT giaquintaalessia mesentericlymphnodesasalternativesiteforpancreaticislettransplantationinadiabeticratmodel
AT verouxpierfrancesco mesentericlymphnodesasalternativesiteforpancreaticislettransplantationinadiabeticratmodel
AT vanellaluca mesentericlymphnodesasalternativesiteforpancreaticislettransplantationinadiabeticratmodel